| Name | Revium Rx. |
|---|---|
| CIK | 0001839140 |
| Tickers | RVRC |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 844516676 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 6467684285 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
14 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-26-120597 | 333-284934 | 261560329 | 34 | 17915 | |||
| 2026-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-26-089070 | 333-284934 | 261273076 | 34 | 2297429 | 1 | 1 | |
| 2026-06-22 | 8-K | CURRENT REPORT | 5.02 | 0001213900-26-070415 | 333-284934 | 261105253 | 34 | 182451 | 1 | 1 |
| 2026-06-01 | 8-K | CURRENT REPORT | 5.02 | 0001213900-26-063235 | 333-284934 | 261047788 | 34 | 183779 | 1 | 1 |
| 2026-05-14 | 10-Q | QUARTERLY REPORT | 0001213900-26-056600 | 333-284934 | 26978775 | 34 | 2295254 | 1 | 1 | |
| 2026-04-20 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001213900-26-045633 | 333-284934 | 26875473 | 34 | 374815 | 1 | 1 |
| 2026-03-31 | 10-K | ANNUAL REPORT | 0001213900-26-037573 | 333-284934 | 26823068 | 34 | 7036194 | 1 | 1 | |
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000363 | 333-284934 | 26585484 | 33 | 1865 | ||
| 2026-01-28 | S-1/A | AMENDMENT NO. 5 TO FORM S-1 | 0001213900-26-008804 | 333-284934 | 26572404 | 33 | 11407298 | |||
| 2026-01-16 | S-1/A | AMENDMENT NO. 4 TO FORM S-1 | 0001213900-26-005242 | 333-284934 | 26540368 | 33 | 2597252 | |||
| 2025-12-12 | S-1/A | AMENDMENT NO. 3 TO FORM S-1 | 0001213900-25-121070 | 333-284934 | 251567371 | 33 | 2635889 | |||
| 2025-10-03 | S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-25-096094 | 333-284934 | 251374054 | 33 | 2657628 | |||
| 2025-08-13 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-075747 | 333-284934 | 251212408 | 33 | 2407215 | |||
| 2025-02-14 | S-1 | REGISTRATION STATEMENT | 0001213900-25-013823 | 333-284934 | 25623584 | 33 | 23178842 | 1 | 1 |
One latest value per concept from companyfacts (97 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 60.73M | 2026-08-13 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 14.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 620,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 575,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 461,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 31.89M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 111,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 111,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 11.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | AssetAcquisitionConsiderationTransferred | AssetAcquisitionConsiderationTransferred | USD | 14.49M | 2024-07-24 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | AssetAcquisitionConsiderationTransferredTransactionCost | AssetAcquisitionConsiderationTransferredTransactionCost | USD | 14.49M | 2024-07-24 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | Assets | Assets | USD | 7.11M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.86M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 5.25M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 842,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 842,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -836,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 250.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 60.73M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 60.73M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 61,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 1,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 2.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 9.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 2.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 664,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | Depreciation | Depreciation | USD | 2,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 575,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056600 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 575,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.02 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 0.02 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | -131,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 96,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 555,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | Goodwill | Goodwill | USD | 2.58M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 11.41M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 8.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | -845,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 358,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -226,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 2.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 457,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayable | Increase (Decrease) in Other Accounts Payable | USD | -309,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -34,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | IndefinitelivedIntangibleAssetsAcquired | Indefinite-lived Intangible Assets Acquired | USD | 3.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 2.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 2.50M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | Liabilities | Liabilities | USD | 1.59M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 7.11M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 971,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 619,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 770,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 331,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -1.17M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -1.47M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | pure | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -1.47M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 84,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 44,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 172,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 18,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 341,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | OtherCommitment | Other Commitment | USD | 1.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -2,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 284,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | PaymentsForFees | Payments for Other Fees | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | PaymentsForProceedsFromShortTermInvestments | Payments for (Proceeds from) Short-term Investments | USD | -350,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 19,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 9,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 916,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 9,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -26.43M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 45,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 111,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | USD/shares | 0.3 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-07-24 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.85 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.045 | 2024-07-24 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 3.53M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056600 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 0.29 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056600 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.53M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056600 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 0.29 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001213900-26-056600 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 111,000 | 2026-06-10 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | SharePrice | Share Price | USD/shares | 1.67 | 2026-06-10 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 5.52M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 5.52M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 437,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001213900-26-037573 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 60.73M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 60.73M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089070 |